… Human papillomavirus (HPV) vaccines are preventive measures to decrease HPV infection
… warts (AGWs) and oral warts (OWs) is limited. To evaluate the efficacy of HPV vaccinations in …

… and related diseases, such as warts and precancerous lesions. In this … oral HPV16 and
18 infections. After a four-year vaccination period, a 93% reduction in the prevalence of oral …

SciELO - Saúde Pública - Human papillomavirus vaccine efficacy in the prevention of anogenital
warts: systematic review and meta-analysis Human papillomavirus vaccine efficacy in …

… Among the reported cases, the present case was the only one to involve a patient with
chronic oral warts who responded to quadrivalent HPV vaccination. This was also the only case …

… The benign lesions induced by HPVs include nongenital and anogenital skin warts, oral and
… A proportion of oral cancer is also attributable to HPV (8, 9). While HPV infection has been …

… At the end of the above-mentioned Costa Rica trial with the bivalent vaccine, the level of
protection against oral HPV 16/18 infection was more than 90% in comparison with the hepatitis …

… oral infections seem to be transmitted by sexual contact, with increased risk associated with
the number of lifetime oral or vaginal sex partners and recent oral … genital warts, this vaccine …

… to healthcare workers who treat anogenital warts, oral warts, and anogenital intraepithelial
… The ACIP recommends routine HPV vaccination at age 11–12 years; the vaccination series …

… human papillomavirus (HPV) infection has been clearly established. Furthermore, non-oncogenic
HPV are responsible for the majority of genital warts. Two prophylactic HPV vaccines …

… of the vaccine against warts and other HPV-related diseases (ie primary prevention) and
research on subjects with already developed cervical intraepithelial disease as well as oral and …